Whippany, NJ, United States of America

Jiahao Zhu

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Novartis Ag. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jiahao Zhu. Retrieved from https://idiyas.com/inventor/jiahao-zhu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jiahao Zhu

Introduction

Jiahao Zhu is an accomplished inventor based in Whippany, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid dosage forms. His work has led to advancements that benefit patients and healthcare providers alike.

Latest Patents

Jiahao Zhu holds a patent for "Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same." This patent involves the creation of monolayer, bilayer, and trilayer solid dosage forms that combine valsartan, amlodipine, and hydrochlorothiazide. His innovative approach enhances the effectiveness and delivery of these medications.

Career Highlights

Jiahao Zhu is currently employed at Novartis AG, a leading global healthcare company. His role at Novartis allows him to work on cutting-edge pharmaceutical innovations that aim to improve patient outcomes. With a focus on research and development, he continues to push the boundaries of what is possible in drug formulation.

Collaborations

Throughout his career, Jiahao has collaborated with notable colleagues, including Alan Edward Royce and Madhusudhan Pudipeddi. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their work.

Conclusion

Jiahao Zhu's contributions to the pharmaceutical industry exemplify the impact of innovation in healthcare. His patent and ongoing work at Novartis AG highlight his commitment to improving medication delivery and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…